Rebecca Spinaris, DO
Urology · Greenville, NCNPI 1194285171
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Boston Scientific at 30.9% of the total. 2025 is the largest year on record at $1,189, 4.4 times the $270 reported in 2021. That places this record below the midpoint for urology clinicians in NC, where the typical reported total is $2,562.
Across 70 payments — averaging $38.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$825
- Johnson & Johnson$239
- Myriad Genetic Laboratories, Inc.$236
- Bayer$196
- Sumitomo Pharma America, Inc.$170
- Procept Biorobotics Corporation$138
- plus $864 from 15 others
What the payments were for
- Speaking & faculty fees$1255%
- Food & beverage$2,54495%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 16 | $825 |
| Johnson & Johnson | 6 | $239 |
| Myriad Genetic Laboratories, Inc. | 6 | $236 |
| Bayer | 6 | $196 |
| Sumitomo Pharma America, Inc. | 3 | $170 |
| Procept Biorobotics Corporation | 1 | $138 |
| Janssen Scientific Affairs, LLC | 1 | $129 |
| AbbVie | 7 | $124 |
| Axonics, Inc. | 2 | $106 |
| Endo USA, Inc. | 5 | $93 |
| Dendreon Pharmaceuticals LLC | 3 | $87 |
| Pfizer | 3 | $72 |
| Medtronic | 1 | $65 |
| Olympus America Inc. | 3 | $49 |
| Novartis | 1 | $26 |
| Progenics Pharmaceuticals, Inc. | 1 | $22 |
| AstraZeneca | 1 | $21 |
| Blue Earth Diagnostics | 1 | $21 |
| Merck | 1 | $20 |
| Integra Lifesciences Corporation | 1 | $16 |
| Urogen Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,669 in reported general payments places this provider in the 50th percentile of 434 urology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 15 | $12,642 |
| Estradiol | 20 | $1,936 |
| Tamsulosin Hcl | 74 | $673 |
| Finasteride | 20 | $318 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $189 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $34 |
| Cephalexin | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other urology in Greenville
- Jonathan HamiltonGreenville$224K
- Matthew CollinsGreenville$41K
- Robert LippittSmithfield$11.4M
- Michael KennellyCharlotte$1.3M
- John KasparRaleigh$1.1M
- Judd MoulDurham$1M
- Daniel GeorgeDurham$1M
- Scott MacdiarmidGreensboro$774K
- Glenn PremingerDurham$736K
- Michael LipkinDurham$293K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.